Handelsbanken Fonder’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$715K Buy
39,815
+4,300
+12% +$81.3K ﹤0.01% 1272
2026
Q1
$773K Buy
35,515
+4,400
+14% +$85.2K ﹤0.01% 1153
2025
Q4
$670K Buy
31,115
+5,700
+22% +$120K ﹤0.01% 1205
2025
Q3
$490K Hold
25,415
﹤0.01% 1270
2025
Q2
$435K Sell
25,415
-100
-0.4% -$4.27K ﹤0.01% 1301
2025
Q1
$1.63M Hold
25,515
0.01% 730
2024
Q4
$3.1M Buy
25,515
+1,700
+7% +$208K 0.01% 544
2024
Q3
$2.97M Buy
23,815
+2,600
+12% +$359K 0.01% 543
2024
Q2
$3.35M Buy
21,215
+2,900
+16% +$373K 0.01% 468
2024
Q1
$2.37M Buy
18,315
+1,500
+9% +$184K 0.01% 560
2023
Q4
$1.62M Buy
16,815
+900
+6% +$86.3K 0.01% 610
2023
Q3
$1.93M Buy
15,915
+2,013
+14% +$228K 0.01% 553
2023
Q2
$1.59M Buy
13,902
+900
+7% +$116K 0.01% 593
2023
Q1
$1.79M Buy
13,002
+1,400
+12% +$182K 0.01% 554
2022
Q4
$1.5M Hold
11,602
0.01% 562
2022
Q3
$1.28M Hold
11,602
0.01% 590
2022
Q2
$870K Sell
11,602
-1,500
-11% -$110K 0.01% 740
2022
Q1
$1.02M Hold
13,102
0.01% 789
2021
Q4
$1.18M Hold
13,102
0.01% 812
2021
Q3
$1.21M Hold
13,102
0.01% 804
2021
Q2
$1.02M Sell
13,102
-1,600
-11% -$121K 0.01% 911
2021
Q1
$1.1M Sell
14,702
-39,500
-73% -$3.64M 0.01% 797
2020
Q4
$9.24M Hold
54,202
0.06% 292
2020
Q3
$7.61M Hold
54,202
0.06% 283
2020
Q2
$8.69M Buy
54,202
+22,702
+72% +$3.09M 0.07% 240
2020
Q1
$3.08M Buy
31,500
+10,000
+47% +$1.14M 0.07% 151
2019
Q4
$2.77M Hold
21,500
0.05% 171
2019
Q3
$1.62M Hold
21,500
0.03% 170
2019
Q2
$3.27M Sell
21,500
-5,000
-19% -$608K 0.06% 166
2019
Q1
$3.16M Hold
26,500
0.06% 161
2018
Q4
$2.89M Sell
26,500
-6,000
-18% -$750K 0.06% 152
2018
Q3
$5.25M Buy
32,500
+3,000
+10% +$410K 0.1% 144
2018
Q2
$3.9M Sell
29,500
-4,000
-12% -$377K 0.08% 154
2018
Q1
$2.48M Buy
33,500
+12,000
+56% +$800K 0.05% 168
2017
Q4
$1.2M Buy
+21,500
New +$1.14M 0.03% 162

Other funds holding SRPT